Clinical Trials Logo

Clinical Trial Summary

This study aims to assess Auto-Adjustable MOBIDERM® Autofit Armsleeve effect on upper limb volume excess after 3 months of maintenance phase treatment in patients with secondary upper limb lymphedema following breast cancer. Half of the patient will wear a day-time and night time compression garment (MOBIDERM Autofit) for 3 months during the maintenance phase, while the other half will only wear day-time compression garment.


Clinical Trial Description

The gold standard treatment to achieve volume reduction of lymphedema is based on a Decongestive Lymphedema Therapy (DLT).that consists in 2 consecutive phases: the initial intensive phase which aim is to obtain maximal reduction of lymphedema volume and a second, the maintenance phase which aim is to maintain the initial volumetric reduction achieved during phase 1 as long as possible. The second maintenance phase mostly based on patient self-management of his treatment, is not strictly codified, but includes compression therapy, nutritional recommendations, skin cares, physical exercises and manual lymphatic drainage. 24 hours compression using garments or bandages seems to be crucial for long term management of lymphedema. Garment and bandages prescriptions for daily treatment are a common practice in the maintenance phase but are often unsuitable for night treatment, as bandages are effective when well applied but are highly dependent on the patients' skills, and garments, due to their nature, can be poorly tolerated leading to low adherence from patients to self-management care. In the end, there is an unmet medical need for night treatment during maintenance phase. . In this context THUASNE developed a specific night-time garment, for lymphedema maintenance phase. It is a standard Auto-Adjustable Armsleeve using the MOBIDERM® technology. MOBIDERM® AUTOFIT is a standard self-adjusting compressive MOBIDERM® sleeve, with mitten. Several small rigid straps are placed throughout the product to facilitate the passage of the arm, to adapt the garment to the morphology of each patient and to tighten it. A first pilot randomized controlled study demonstrated some benefit to use MOBIDERM Autofit during night-time as an adjuvant treatment to daily compressive garment. The objective of this new study is to confirm, using a more robust methodology, the effect of Auto-Adjustable MOBIDERM® Autofit Armsleeve on maintenance phase treatment, worn during the night, within the period at risk for the so called rebound effect as reported in several observational studies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04203069
Study type Interventional
Source Thuasne
Contact ISABELLE QUERE, PUPH, MD
Phone +33467337028
Email i-quere@chu-montpellier.fr
Status Recruiting
Phase N/A
Start date July 1, 2020
Completion date February 15, 2024

See also
  Status Clinical Trial Phase
Completed NCT03492476 - Circaid® Compression Sleeve Versus Short-stretching Bandage in Upper Limb Lymphatic Edema N/A
Completed NCT03676127 - Diagnostic Accuracy of Dermal Thickness in Lymphedema
Completed NCT04570722 - Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study) N/A
Completed NCT06230913 - Kinesiotaping Versus Pressure Garments on Secondary Upper Extremity Lymphedema. N/A
Recruiting NCT03210311 - Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema N/A
Not yet recruiting NCT04435639 - Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema N/A
Active, not recruiting NCT02691624 - Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation
Not yet recruiting NCT04139291 - Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy N/A
Recruiting NCT04138667 - Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema N/A
Recruiting NCT04296929 - The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema. N/A
Recruiting NCT06144164 - A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer Phase 3
Completed NCT05278871 - Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors N/A
Recruiting NCT04908254 - A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema N/A
Completed NCT04881604 - Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema N/A
Recruiting NCT05203835 - Trial of Acebilustat for the Treatment of Upper Arm Lymphedema Phase 2
Recruiting NCT04934098 - Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema N/A
Withdrawn NCT04246034 - Microvascular Breast Reconstruction With Lymph Node Transfer N/A
Completed NCT04213001 - Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema N/A
Recruiting NCT04690439 - Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema N/A
Completed NCT06009666 - Elastographic and Ultrasonographic Evaluation of Patients With Breast Cancer Related Lymphedema